CRISPR Therapeutics AG (NASDAQ:CRSP) currently has a daily average trading volume of 1.71M but it saw 1341870 shares traded in last market. With a market cap of 4.57B USD, the company’s current market price of $53.81 came rising about 1.55 while comparing to the previous closing price of $52.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $91.10 and as low as $37.55.
Taking a look at 20-day trading activity of CRISPR Therapeutics AG (CRSP) gives us an average price of $58.15, while its current price level is -40.93% below from 52-week high level whereas it is 43.30% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $69.22 while that of 200 days or SMA-200 reads an average of $59.49. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.81% during that period while stretching the period over a month that increases to 4.00%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 30.75 which implies that the stock is in neutral territory.
TD Cowen downgraded its recommendation for the stock as a “Underperform” from “Market Perform” on December 11, 2023 while assigning a price target of $30.
Over the week, CRSP’s stock price is moving -3.31% down while it is -17.25% when we observe its performance for the past one month. Year-to-date it is -14.04% down and over the past year, the stock is showing an upside performance of 9.95%.
Currently, CRISPR Therapeutics AG’s total number of outstanding shares is 84.88M. Company’s return on investment (ROI) stands at -7.29% and return on equity (ROE) at -8.17%. Stock’s beta reads 1.79. Stock has a price to book (P/B) ratio of 2.29 while price to sale or P/S ratio amounts to 12.30. Its return on asset (ROA) is -6.87% on average.
